Loading
Dong-A ST
Dong-A ST is a Seoul pharmaceutical company, the prescription-medicine arm of one of Korea's oldest drug groups, which sponsors phase 3 cancer trials including biosimilars and supportive-care products.
Also called: Dong-A ST Co., Ltd.Dong-A Socio Holdings
Overview
Dong-A ST Co., Ltd. was formed in 2013 when the Dong-A group split its prescription business from its consumer arm. It develops and markets prescription medicines in Korea and abroad, including oncology supportive-care products, a pegylated G-CSF and biosimilars developed with partners, and it acts as lead sponsor of phase 3 cancer trials registered on ClinicalTrials.gov.
Connected
3Similar pages
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyVion Pharmaceuticals
- CompanyCyclacel Pharmaceuticals
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
donga-st.com · 1
wikidata.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/